Effect of mat Pilates on the blood pressure at rest and quality of life in persons with high blood pressure

Not Applicable

• Conditions: Health Condition 1: I10- Essential (primary) hypertension

• Registration Number: CTRI/2021/07/035002
• Lead Sponsor: ivedita S Prabhu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1)Newly physician diagnosed and all participants with well controlled systemic arterial hypertension receiving antihypertensive drug therapy.

2)Systemic Hypertension

Prehypertension (systolic blood pressure > 130 mm Hg - <139 mm Hg or diastolic blood pressure > 80 mm Hg - 89 mm Hg)12

Stage 1 (systolic blood pressure >140 - 159 mm Hg or diastolic blood pressure > 90 - 99 mm Hg)

Exclusion Criteria

1)Stage 2 hypertension â?? systolic blood pressure >160 mm Hg and diastolic blood pressure >100mm Hg12

2)Accelerated hypertension/Hypertensive crisis

3)Any change of antihypertensive drug regime (dosage) during the study period.

4)Current h/o Cardiac Arrhythmias (on external or internal pacing devices, Implanted Cardioverter defibrillator (ICD))

5)Pregnancy and Lactation

6)Known h/o valvular heart disease (aortic, mitral, tricuspid, pulmonic)

7)Known h/o malignancy â?? on previous or current chemotherapy, radiation therapy

8)Known c/o acute renal insufficiency

9)Known h/o neurological disease

10)Known h/o arterial aneurysms

11)Known case of musculoskeletal trauma with disability

12)Known h/o of vertigo

13)Inability to comprehend and follow instructions for the Mat Pilates exercises

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1)Resting arterial systolic and diastolic blood pressure (mm Hg) <br/ ><br>2)Central Systolic blood pressure (mm Hg) <br/ ><br>3)Central Pulse pressure (mm Hg) <br/ ><br>4)Mean Arterial pressure (mm Hg) <br/ ><br>Timepoint: Baseline - Day 0 (Week 1) <br/ ><br>Post - Day 90 (Week 12)

Secondary Outcome Measures

Name	Time	Method
1)World Health Organization BREF Health Related Quality of Life (WHO BREF questionnaire scores) <br/ ><br>2)Left ventricular ejection fraction (%) <br/ ><br>3)Left ventricular end diastolic volume (ml) <br/ ><br>Timepoint: Baseline - Day 0 (Week 1) <br/ ><br>Post - Day 90 (Week 12)